Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Pseudostellaria heterophylla polysaccharides for the treatment of diabetes-related lower extremity ischemia.

PROVIDER: PRJNA1273453 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR33875976.fastq.gz	Fastqsanger.gz
	SRR33875977.fastq.gz	Fastqsanger.gz
	SRR33875978.fastq.gz	Fastqsanger.gz
	SRR33875979.fastq.gz	Fastqsanger.gz
	SRR33875980.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Pseudostellaria heterophylla

Project description:Pseudostellaria heterophylla overview

| PRJNA316756 | ENA

Pseudostellaria heterophylla

Project description:Pseudostellaria heterophylla Transcriptome

| PRJNA818791 | ENA

Pseudostellaria heterophylla

Project description:Pseudostellaria heterophylla Raw sequence reads

| PRJNA314009 | ENA

Pseudostellaria heterophylla

Project description:Pseudostellaria heterophylla Raw sequence reads

| PRJNA818490 | ENA

Pseudostellaria heterophylla

Project description:Pseudostellaria heterophylla Raw sequence reads

| PRJNA1035997 | ENA

Project description:Chloroplast genome sequences of Pseudostellaria heterophylla

| PRJNA932041 | ENA

Pseudostellaria heterophylla

Project description:Pseudostellaria heterophylla Transcriptome or Gene expression

| PRJNA272955 | ENA

Project description:Molecular mechanism of germplasm deterioration of Pseudostellaria heterophylla

| PRJNA766712 | ENA

Evaluation of a novel clinical platform for cardiovascular drug development

Project description:Objectives M-bM-^@M-^STo determine whether inflammation biomarkers can be used as indicators of therapeutic response, an exploratory study was performed to ascertain whether short term improvements in risk parameters will have measureable effects on a pre-defined panel of plaque inflammation biomarkers. Methods and Results M-bM-^@M-^S Patients (n=121) with peripheral arterial disease were enrolled into one of three sub-studies based upon the presence of hypercholesterolemia, hypertension, or diabetes. Patients were randomized to 6 weeks of drug treatment vs. placebo and underwent catheter excision of atherosclerotic tissue from one extremity at baseline and the contralateral extremity after treatment. Simvastatin 40mg once daily reduced LDL-C by 43% (p<0.01), losartan 50mg once daily reduced diastolic blood pressure by 4 mm Hg (p=0.099), and pioglitazone 30mg once daily reduced serum glucose by 66mg/dL (p=0.008). Despite these effects, there were no consistent treatment effects on a large panel of plaque protein, RNA and lipid biomarkers. Conclusions M-bM-^@M-^S Short term treatment with drugs that improve cardiovascular risk parameters did not result in a measureable reduction in the levels of peripheral arterial plaque inflammation biomarkers. Further studies are required to identify biomarkers that are sufficiently predictive to be used to identify drug candidates for testing in large cardiovascular outcome studies. (ClinicalTrials.gov: NCT00720577) Human peripheral atherosclerosis plaque was extracted from lower extremities, and RNA, lipids and proteins extracted. RNA was analyzed in an Agilent two-color platform.

2012-05-15 | E-GEOD-37824 | biostudies-arrayexpress

Project description:Key Tailoring Gene Identification for Novel Orbitides Mining in Pseudostellaria heterophylla

| PRJNA1182908 | ENA